C4 Therapeutics, Inc. - Common Stock (NQ:CCCC)
All News about C4 Therapeutics, Inc. - Common Stock
CCCC Revenue Drops 46%
August 07, 2025
Via The Motley Fool


C4 Therapeutics to Participate in Upcoming March Investor Conferences
February 24, 2025
Via GlobeNewswire



Via Benzinga




Via GlobeNewswire





Via GlobeNewswire

Via GlobeNewswire

C4 Therapeutics Announces Delivery of Second Development Candidate to Biogen
September 10, 2024
Via GlobeNewswire

Via Benzinga




Via GlobeNewswire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.